S. Schülke

Cells · 2020

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from S. Schülke's perspective

Ordered by how strongly the researchers S. Schülke trusts endorse each paper. Same corpus, a different order for every researcher.

  1. New therapies for treatment of rheumatoid arthritis. (The Lancet)
  2. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. (New England Journal of Medicine)
  3. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007 (Arthritis & Rheumatism)
  4. Inflammatory bone loss: pathogenesis and therapeutic intervention (Nature reviews. Drug discovery)
  5. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. (American Journal of Pathology)
  6. Evidence that cytokines play a role in rheumatoid arthritis. (Journal of Clinical Investigation)
  7. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving… (Arthritis & Rheumatism)
  8. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. (Arthritis & Rheumatism)
  9. IL-23-IL-17 immune axis: Discovery, Mechanistic Understanding, and Clinical Testing
  10. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease (Nature Medicine)

Their papers